Skip to main content
Michael Haggenmueller

Dr. Yuval Rinkevich

Director
+49 89 3187 4685Email meBuilding/Room: C3.11

“Regenerative medicine encompasses our scientific desire to understand and capitalize on nature’s tools for healing. Our goal is to uncover novel tissue repair mechanisms that can be exploited to restore diseased and injured tissues..”

“Regenerative medicine encompasses our scientific desire to understand and capitalize on nature’s tools for healing. Our goal is to uncover novel tissue repair mechanisms that can be exploited to restore diseased and injured tissues.”

Academic Pathway & Research Area

Dr. Rinkevich has been working at the cutting edge of our understanding of tissue/organ repair and regeneration for over 20 years. His passion and commitment to understanding healing responses and tissue rejuvenation has led his career track from the point of obtaining his PhD degree from the Technion-Israel Institute of Technology, where he studied whole body regeneration from single blood vessels in Protochordates.  Dr Rinkevich moved to Stanford University in the US where he investigated pivotal cellular lineages and stem cells in coordinating mammalian tissue repair and regeneration. His work at Stanford projected Dr Rinkevich into the forefront of the tissue repair field, uncovering the role of Engrailed-1 positive cells in the transition from scarless to scar forming tissue responses.

Today Dr Rinkevich is the Director of the Helmholtz Institute of Regenerative Biology and Medicine at the Helmholtz Center, Munich, Germany. His lab fuses a focus on basic biology, continuing to push forward our understanding of tissue/organ repair and regeneration, with a vision to applying these findings to drug development strategies and translation to the clinic. Publication in high impact journals including Nature and Science, numerous patents and supported by prestigious awards such as the ERC Consolidator Grant, highlight the quality of his team’s work. Dr Rinkevich’s latest work describing the role of fascia and transfer of extracellular matrix in tissue scarring and fibrosis in multiple organ systems is reinventing the way we look at tissue repair and regeneration. These findings provide a new perspective on the potential for clinical intervention, opening our minds to a revolution in antifibrotic therapy, a clinical area impacting fields of medicine from oncology to hepatology and pulmonology, and the potential to prevent and potentially resolve fibrotic disease.

Fields of Work and Expertise

Developmental Biology Stem Cell BiologyPathologyTissue Repair and Regeneration Fibrosis ScarringHealing Extra-cellular Matrix 

Professional Background

2015

Group Leader

2018

ERC Consolidator Grant awarded

2019

Director, Institute of Regenerative Biology and Medicine

Honors and Awards

2016
HFSP Career Development Award

Honors and Awards

2021
Employee of the Year Award
2020
The Innovative Research Award
2020
The Research Excellence Award

Publications

Read more